Skip to main content
Clinical Trials/NCT05690399
NCT05690399
Not yet recruiting
Not Applicable

Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer in 2 Centers in Asyut

Assiut University0 sites100 target enrollmentJanuary 2023
ConditionsProstate Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
Assiut University
Enrollment
100
Primary Endpoint
Clinical and pathological characteristics and routine treatment of patients with prostate cancer in 2 centers in Asyut in previous 10 years
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

To evaluate clinical and pathological characteristics and treatment protocol and outcomes of patients with prostate cancer in 2 centers of Asyut from 2013 to 2023

Detailed Description

Inclusion criteria : * Male patient , Age ≥ 40 yo * Diagnosed as prostate cancer from ( 2013- 2023 ) proved by biopsy in South Egypt Cancer Institute "SECI" \& Asyut clinical oncology department * Newly diagnosed/ metastatic at presentation * ECOG 0-4 • Exclusion criteria: * Having Other types of malignancy.

Registry
clinicaltrials.gov
Start Date
January 2023
End Date
April 2024
Last Updated
3 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Aml Mohamed Haridy

Evaluation of clinical and pathological characteristics and routine treatment of patients with prostate cancer in 2 centers in Asyut

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Male patient , Age ≥ 40 yo
  • Diagnosed as prostate cancer from ( 2013- 2023 ) proved by biopsy
  • Newly diagnosed/ metastatic at presentation

Exclusion Criteria

  • Having Other types of malignancy.

Outcomes

Primary Outcomes

Clinical and pathological characteristics and routine treatment of patients with prostate cancer in 2 centers in Asyut in previous 10 years

Time Frame: Baseline

Clinical and pathological characteristics and routine treatment of patients with prostate cancer in 2 centers in Asyut in previous 10 years

Similar Trials